SRI 63072: structure given in first source; PAF antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 128177 |
| SCHEMBL ID | 8705053 |
| MeSH ID | M0142556 |
| Synonym |
|---|
| sri 63072 |
| 2-(4-hydroxy-1,3-thiazol-3-ium-3-yl)ethyl [2-(octadecylcarbamoyloxymethyl)oxolan-2-yl]methyl phosphate |
| 3-(2-((2-octadecylaminocarbonyloxymethyltetrahydro-2-furanylmethoxy)hydroxyphosphinyloxy)ethyl)thiazolium hydroxide inner salt-4-oxide |
| sri-63-072 |
| 102841-49-6 |
| thiazolium, 4-hydroxy-3-(2-((hydroxy((tetrahydro-2-((((octadecylamino)carbonyl)oxy)methyl)-2-furanyl)methoxy)phosphinyl)oxy)ethyl)-, hydroxide, inner salt, (+-)- |
| SCHEMBL8705053 |
| DTXSID90908086 |
| (2-{[hydroxy(octadecylimino)methoxy]methyl}oxolan-2-yl)methyl 2-(4-hydroxy-1,3-thiazol-3-ium-3-yl)ethyl phosphate |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||